IDH1 and central nervous system cancer: In addition, although the IDH1 gene has been discovered as a predictor of glioma survival in previous studies (48–50), it could not distinguish GBM patients in our Chinese populations (Supplementary Figure S6), suggesting the underlying genetic heterogeneity among different populations.